Search results

Evidence-based recommendations on adefovir dipivoxil (Hepsera) and peginterferon alfa-2a (Pegasys) for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

22 February 2006

This guideline covers assessing and managing chronic hepatitis B in children, young people and adults. It aims to improve care for people with hepatitis B by specifying which tests and treatments to use for people of different ages and with different disease severities.

Result type

Clinical guideline

Last updated

20 October 2017

Evidence-based recommendations on interferon alfa (Pegasys or ViraferonPeg) and ribavirin for people with chronic hepatitis C.

Result type

Technology appraisal guidance

Last updated

27 November 2013

Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin for treating chronic hepatitis C in adults.

Result type

Technology appraisal guidance

Published

22 September 2010

Evidence-based recommendations on peginterferon alfa (Pegasys) and ribavirin for people with mild chronic hepatitis C.

Result type

Technology appraisal guidance

Last updated

27 November 2013

Evidence-based recommendations on peginterferon alfa (Pegasys; ViraferonPeg) and ribavirin (Copegus) for treating chronic hepatitis C in children and young people.

Result type

Technology appraisal guidance

Published

27 November 2013

Evidence-based recommendations on entecavir for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

27 August 2008

Evidence-based recommendations on sofosbuvir (Sovaldi) for treating some types of chronic hepatitis C (HCV)

Result type

Technology appraisal guidance

Published

25 February 2015

Evidence-based recommendations on bulevirtide (Hepcludex) for chronic hepatitis D in adults.

Result type

Technology appraisal guidance

Published

7 June 2023